🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the service has taken down violative material and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

Within minutes of entering one group, a vendor posted contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these communities, messages display black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Although the research behind this drug is valid, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has already seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to possibly serious health risks”.